We all know that investing in early-stage companies is a very risky proposition, and the majority of investments will either fail completely or fail to return the capital invested.
The reasons for failure are diverse, but almost never due to fraud. Unfortunately, the intense media coverage of a few spectacular failures such as Theranos and FTX (and the fraud associated with them) have sadly led many policy makers in Washington DC to conclude that fraud is rampant in this asset class and therefore further regulation is necessary to help “protect” investors. This perception is a remarkable misunderstanding, and this article will present data and analysis to set the record straight. It is also regrettable since some of these notable failures (such as Theranos) never received funding from any organized Angel Group, all of which follow a rigorous due diligence process, so in that sense there is not a prevalent problem with fraud in investments by Angel Groups after appropriate due diligence.
Many studies have shown the failure rate in this asset class is over 50%. For Tech Coast Angels, 32% of the companies and 68% of the outcomes failed to return the capital invested:
FIGURE 1: TCA Outcomes from 526 Portfolio Companies